170 related articles for article (PubMed ID: 16824852)
1. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative.
Hsia J; Criqui MH; Herrington DM; Manson JE; Wu L; Heckbert SR; Allison M; McDermott MM; Robinson J; Masaki K;
Am Heart J; 2006 Jul; 152(1):170-6. PubMed ID: 16824852
[TBL] [Abstract][Full Text] [Related]
2. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
Hsia J; Langer RD; Manson JE; Kuller L; Johnson KC; Hendrix SL; Pettinger M; Heckbert SR; Greep N; Crawford S; Eaton CB; Kostis JB; Caralis P; Prentice R;
Arch Intern Med; 2006 Feb; 166(3):357-65. PubMed ID: 16476878
[TBL] [Abstract][Full Text] [Related]
3. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
Hsia J; Criqui MH; Rodabough RJ; Langer RD; Resnick HE; Phillips LS; Allison M; Bonds DE; Masaki K; Caralis P; Kotchen JM;
Circulation; 2004 Feb; 109(5):620-6. PubMed ID: 14769684
[TBL] [Abstract][Full Text] [Related]
4. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
[TBL] [Abstract][Full Text] [Related]
5. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.
Hendrix SL; Wassertheil-Smoller S; Johnson KC; Howard BV; Kooperberg C; Rossouw JE; Trevisan M; Aragaki A; Baird AE; Bray PF; Buring JE; Criqui MH; Herrington D; Lynch JK; Rapp SR; Torner J;
Circulation; 2006 May; 113(20):2425-34. PubMed ID: 16702472
[TBL] [Abstract][Full Text] [Related]
6. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
[TBL] [Abstract][Full Text] [Related]
7. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
8. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
[TBL] [Abstract][Full Text] [Related]
9. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
10. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial.
Brunner RL; Gass M; Aragaki A; Hays J; Granek I; Woods N; Mason E; Brzyski R; Ockene J; Assaf A; LaCroix A; Matthews K; Wallace R;
Arch Intern Med; 2005 Sep; 165(17):1976-86. PubMed ID: 16186467
[TBL] [Abstract][Full Text] [Related]
11. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG
Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990
[TBL] [Abstract][Full Text] [Related]
13. Venous thrombosis and conjugated equine estrogen in women without a uterus.
Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
[TBL] [Abstract][Full Text] [Related]
14. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement therapy and cognitive function].
Huang CP; Hong CT; Huang IT
Acta Neurol Taiwan; 2006 Dec; 15(4):273-7. PubMed ID: 17214093
[TBL] [Abstract][Full Text] [Related]
16. Use of oral conjugated estrogen alone and risk of breast cancer.
Zhang SM; Manson JE; Rexrode KM; Cook NR; Buring JE; Lee IM
Am J Epidemiol; 2007 Mar; 165(5):524-9. PubMed ID: 17132697
[TBL] [Abstract][Full Text] [Related]
17. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.
LaCroix AZ; Chlebowski RT; Manson JE; Aragaki AK; Johnson KC; Martin L; Margolis KL; Stefanick ML; Brzyski R; Curb JD; Howard BV; Lewis CE; Wactawski-Wende J;
JAMA; 2011 Apr; 305(13):1305-14. PubMed ID: 21467283
[TBL] [Abstract][Full Text] [Related]
18. Effect of estrogen therapy on gallbladder disease.
Cirillo DJ; Wallace RB; Rodabough RJ; Greenland P; LaCroix AZ; Limacher MC; Larson JC
JAMA; 2005 Jan; 293(3):330-9. PubMed ID: 15657326
[TBL] [Abstract][Full Text] [Related]
19. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys.
Appt SE; Clarkson TB; Lees CJ; Anthony MS
Maturitas; 2006 Sep; 55(2):187-94. PubMed ID: 16574351
[TBL] [Abstract][Full Text] [Related]
20. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
Stefanick ML; Anderson GL; Margolis KL; Hendrix SL; Rodabough RJ; Paskett ED; Lane DS; Hubbell FA; Assaf AR; Sarto GE; Schenken RS; Yasmeen S; Lessin L; Chlebowski RT;
JAMA; 2006 Apr; 295(14):1647-57. PubMed ID: 16609086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
